精巣腫瘍化学療法後の残存腫瘍に対する治療

HANDLE Web Site オープンアクセス
  • 稲元, 輝生
    大阪医科大学泌尿生殖・発達医学講座泌尿器科学
  • 東, 治人
    大阪医科大学泌尿生殖・発達医学講座泌尿器科学

書誌事項

タイトル別名
  • Comprehensive Management of Residual Tumor in Patients with an Advanced Testicular Tumor
  • セイソウ シュヨウ カガク リョウホウ ゴ ノ ザンソン シュヨウ ニ タイスル チリョウ

この論文をさがす

抄録

Treatment for metastatic testicular tumors is based on risk stratification according to International Germ Cell Cancer Collaborative Group classification and consists of cisplatin-based chemotherapy and resection of residual tumors. The indication of residual tumor resection is sometimes controversial. The residual tumor is under surveillance without resection after chemotherapy of pure seminoma, but the residual tumor is resected after chemotherapy in most cases of nonseminomatous tumors. The Japanese Urological Association has established guidelines on testicular tumor useful for the evidence-based treatment in Japan. The indication and surgical techniques for retroperitoneal residual tumor resection after chemotherapy are discussed.

収録刊行物

  • 泌尿器科紀要

    泌尿器科紀要 58 (12), 737-742, 2012-12

    泌尿器科紀要刊行会

詳細情報 詳細情報について

問題の指摘

ページトップへ